Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–50 of 4152 results
Advanced filters: Author: Mark F. Fisher Clear advanced filters
  • The existing ENCODE registry of candidate human and mouse cis-regulatory elements is expanded with the addition of new ENCODE data, integrating new functional data as well as new cell and tissue types.

    • Jill E. Moore
    • Henry E. Pratt
    • Zhiping Weng
    ResearchOpen Access
    Nature
    P: 1-10
  • Inhibition of the histone methyltransferase NSD2 and the androgen receptor in preclinical models can reverse lineage plasticity to suppress tumour growth and promote cell death in multiple subtypes of castration-resistant prostate cancer.

    • Jia J. Li
    • Alessandro Vasciaveo
    • Michael M. Shen
    ResearchOpen Access
    Nature
    Volume: 649, P: 216-226
  • Analysis of a placebo-controlled trial of a BCMA-targeting CAR-T cell therapy in patients with myasthenia gravis shows that CAR-T cell infusion selectively remodels the systemic immune environment, with elimination of BCMA-high plasma cells and activated plasmacytoid dendritic cells and changes in the autoreactive B cell repertoire.

    • Renee R. Fedak
    • Rachel N. Ruggerie
    • Kelly Gwathmey
    ResearchOpen Access
    Nature Medicine
    P: 1-13
  • DEAD-box helicase 6 (DDX6), the regulator of P-body assembly, is essential for the survival of acute myeloid leukemia (AML) cells. Here the authors report that DDX6 undergoes phase separation to preserve mRNA subsets in P-bodies, promoting branched-chain amino acid metabolism and chemoresistance in AML.

    • Hongjie Bi
    • Wei Li
    • Rui Su
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-21
  • This study provides new insights into the role of endoglin (ENG) as a co-receptor in endothelial cells and addresses a gap-in-knowledge on how ENG could be involved in both TGF-β and BMP9 signalling. Such knowledge greatly facilitates therapeutic targeting of ENG-related pathways.

    • Jingxu Guo
    • Karolina Kostrzyńska
    • Wei Li
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-20
  • Here the authors show that endogenous or therapeutically delivered GDF-15 activates brainstem neurons that trigger splenic β-adrenergic signaling. This, in turn, suppresses autoreactive T cells and reduces neuroinflammation, identifying a possible target for multiple sclerosis treatment.

    • Jana K. Sonner
    • Audrey Kahn
    • Manuel A. Friese
    ResearchOpen Access
    Nature Immunology
    P: 1-13
  • Cosgun et al. show that, in B cell leukemia, β-catenin expression is maintained at low levels through glycogen synthase kinase 3B (GSK3β)-mediated phosphorylation. Inhibition of GSK3β results in β-catenin–Ikaros–NuRD complex formation, leading to B-ALL cell death through MYC repression.

    • Kadriye Nehir Cosgun
    • Huda Jumaa
    • Markus Müschen
    ResearchOpen Access
    Nature Cancer
    P: 1-19
  • Large-effect variants in autism remain elusive. Here, the authors use long-read sequencing to assemble phased genomes for 189 individuals, identifying pathogenic variants in TBL1XR1, MECP2, and SYNGAP1, plus nine candidate structural variants missed by short-read methods.

    • Yang Sui
    • Jiadong Lin
    • Evan E. Eichler
    ResearchOpen Access
    Nature Communications
    P: 1-16
  • Spatial transcriptomic analysis of cells in intestinal fistulae of patients with Crohn’s disease reveals the existence of specialized fistula-associated cell states with distinct signalling profiles and extracellular matrix architecture.

    • Colleen McGregor
    • Xiao Qin
    • Alison Simmons
    ResearchOpen Access
    Nature
    Volume: 649, P: 703-712
  • Gonzalez-Gallego et al. developed a fully iPS-cell-based human three-dimensional blood–brain barrier (BBB) model and used it to study roles of the stroke risk gene FOXF2 in BBB dysregulation, demonstrating its applicability for mechanistic research and drug development.

    • Judit González-Gallego
    • Katalin Todorov-Völgyi
    • Dominik Paquet
    ResearchOpen Access
    Nature Neuroscience
    P: 1-14
  • How the brain supports speaking and listening during conversation of its natural form remains poorly understood. Here, by combining intracranial EEG recordings with Natural Language Processing, the authors show broadly distributed frontotemporal neural signals that encode context-dependent linguistic information during both speaking and listening..

    • Jing Cai
    • Alex E. Hadjinicolaou
    • Sydney S. Cash
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-13
  • Linking prior epigenetic status to future outcomes remains a challenge. Here, authors show recording neuronal enhancer activity across postnatal development in mice reveals loci that predict and can be manipulated to modify acute seizure response.

    • Benjamin D. Boros
    • Mariam A. Gachechiladze
    • Timothy M. Miller
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-14
  • Recently published results from a Phase I trial showed the blood brain barrier could be transiently opened in glioblastoma patients using low-intensity ultrasound and microbubbles. Here, the authors develop a microfluidic chip to capture tumour-derived extracellular vesicles and particles in response to paclitaxel treatment.

    • Mark W. Youngblood
    • Abha Kumari
    • Adam M. Sonabend
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-15
  • Hutchinson-Gilford Progeria Syndrome is characterized by premature aging with cardiovascular disease being the main cause of death. Here the authors show that inhibition of the NAT10 enzyme enhances cardiac function and fitness, and reduces age-related phenotypes in a mouse model of premature aging.

    • Gabriel Balmus
    • Delphine Larrieu
    • Stephen P. Jackson
    ResearchOpen Access
    Nature Communications
    Volume: 9, P: 1-14
  • The variability in clinical outcomes of SARS-CoV-2 infection is partly due to deficiencies in production or response to type I interferons (IFN). Here, the authors describe a FIP200-dependent lysosomal degradation pathway, independent of canonical autophagy and type I IFN, that restricts SARS-CoV-2 replication, offering insights into critical COVID-19 pneumonia mechanisms.

    • Lili Hu
    • Renee M. van der Sluis
    • Trine H. Mogensen
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-23
  • Climate change can alter when and how animals grow, breed, and migrate, but it is unclear whether this allows populations to persist. This global study shows that shifts in seasonal timing are key to helping vertebrate species maintain population growth under global warming.

    • Viktoriia Radchuk
    • Carys V. Jones
    • Martijn van de Pol
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-14
  • Bioactive sesquiterpenes accumulating in petunia stigmas are synthesized in the floral tube and then transported to the pistil via natural fumigation within the internal airspace of the developing flower.

    • Benoît Boachon
    • Joseph H. Lynch
    • Natalia Dudareva
    Research
    Nature Chemical Biology
    Volume: 15, P: 583-588
  • In this phase 1 trial, treatment of patients with fibrolamellar hepatocellular carcinoma with a therapeutic peptide vaccine targeting the fusion kinase DNAJB1–PRKACA, which is the driver of the disease, together with nivolumab and ipilimumab, was safe and led to encouraging preliminary clinical responses, and translational analysis showed activation of immune responses.

    • Marina Baretti
    • Allison M. Kirk
    • Mark Yarchoan
    ResearchOpen Access
    Nature Medicine
    Volume: 31, P: 4246-4255
  • A fresh approach to protein design that incorporates excited intermediate states enables precise control over the lifetime of protein interactions, with potential applications in cell-signalling modulation and in biosensors and synthetic circuits.

    • Adam J. Broerman
    • Christoph Pollmann
    • David Baker
    ResearchOpen Access
    Nature
    Volume: 647, P: 528-535
  • Understanding deregulation of biological pathways in cancer can provide insight into disease etiology and potential therapies. Here, as part of the PanCancer Analysis of Whole Genomes (PCAWG) consortium, the authors present pathway and network analysis of 2583 whole cancer genomes from 27 tumour types.

    • Matthew A. Reyna
    • David Haan
    • Christian von Mering
    ResearchOpen Access
    Nature Communications
    Volume: 11, P: 1-17
  • Here the authors show that tissue-resident memory and exhausted T cells in tumors are distinct populations that are shaped by relative presence or absence of TCR signals, suggesting that a tailored therapeutic strategy is needed to target each subset.

    • Thomas N. Burn
    • Jan Schröder
    • Laura K. Mackay
    ResearchOpen Access
    Nature Immunology
    Volume: 27, P: 98-109
  • Neoadjuvant immunochemotherapy against NSCLC has been tested in clinical trials. Here, the authors follow up longer-term survival and measure immune cell phenotype changes in a single-arm phase II clinical trial of neoadjuvant immunochemotherapy, indicating association of intratumoural TCR diversity and CD8 T cell positioning.

    • Dominic Schmid
    • Bettina Sobottka
    • Alfred Zippelius
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-15
  • The evolution of insecticide resistance in the major malaria vector, Anopheles gambiae, remains an important issue in sustainable malaria control in Africa. Here, the authors present a framework for identifying resistance mechanisms before they arise in field mosquito populations. The findings have implications for public health surveillance and vector control.

    • Sofia Balaska
    • Linda Grigoraki
    • Hanafy M. Ismail
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-13
  • Schwannomas are regularly treated with radiotherapy, but the molecular effects on these tumours and their microenvironment remain unclear. Here, the authors show that radiotherapy can induce epigenetic reprogramming and immune infiltration in schwannomas, and develop the snARC-seq approach to analyse the epigenomic evolution at the single-cell level.

    • S. John Liu
    • Tim Casey-Clyde
    • David R. Raleigh
    ResearchOpen Access
    Nature Communications
    Volume: 15, P: 1-19
  • Motivated by the need for a non-living and versatile multiblock semi-crystalline polyolefin synthetic method, the authors report a method for producing previously inaccessible iPP-b-LLDPE linear multiblocks wherein the overall molecular weights, individual block lengths, and crystallinity can be controlled.

    • Abhishek Banerjee
    • Navin Kafle
    • James M. Eagan
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-11
  • Approximately 17% of meningiomas remain genomically uncharacterized. Here, the authors analyze 105 meningiomas without known driver mutations or significant copy number alterations and identify a subgroup of meningiomas, defined by FOS/FOSB gene fusions with distinctive transcriptomic and histopathological features.

    • Kanat Yalcin
    • Hasan Alanya
    • E. Zeynep Erson-Omay
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-15
  • Current single-cell RNA sequencing methods struggle to comprehensively profile transcriptomes, with many lowly expressed transcripts remaining undetected. Here authors present a workflow for enhancing the detection of both transcripts and regions of interest in combination with a standard transcriptome profile.

    • Giulia Moro
    • Izaskun Mallona
    • Konrad Basler
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-22
  • Components of the glycocalyx have been shown to impair immune cell functions, including of CAR-T cells. Here the authors show that CAR-T cell mediated cytotoxicity in pancreatic cancer models can be enhanced by incorporating non-signalling binding domains that target the glycocalyx.

    • Sangwoo Park
    • Cassidy E. Ho
    • Marcela V. Maus
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-15
  • Guetter et al. identify a melanoma-associated chondroitin sulfate proteoglycan-positive subpopulation of metastasis founder cells from lymph node biopsies of patients with melanoma and observe that they mediate immune evasion and predict systemic metastasis and poor outcomes.

    • Severin Guetter
    • Courtney König
    • Melanie Werner-Klein
    ResearchOpen Access
    Nature Cancer
    Volume: 6, P: 1017-1034
  • Brown et al. show that mouse islet progenitors with different transcriptomes produce distinct β-cell subtypes and maternal diet alter the subtype proportions. Similar β-cell subsets exist in humans, with a subset enriched in genes related to β cell function reduced in diabetes.

    • Monica E. Brown
    • Verda E. Miranda
    • Guoqiang Gu
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-20
  • CD27 is a key T-cell costimulatory receptor, but efforts to target CD27 have been limited by the poor clinical efficacy of first-generation anti-CD27 antibodies. The authors here engineer higher-valency antibodies by more effectively engaging CD27 and selectively binding to FcγRIIB, which enhance anti-tumor activity.

    • Marcus A. Widdess
    • Anastasia Pakidi
    • Aymen Al-Shamkhani
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-15
  • SpbK protects Bacillus subtilis from phage infection by depleting NAD⁺. In this study, the authors uncover the molecular mechanisms underlying SpbK’s self association-dependent NADase activity and its activation by the SPβ phage portal protein YonE.

    • Biswa P. Mishra
    • Christian L. Loyo
    • Thomas Ve
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-16
  • Analysis of 14,106 tumor genomes highlights recurrent mutations in mitochondrial ribosomal RNA encoded within the mitochondrial genome. Mutations occur at hotspot positions and are under strong purifying selection in the germline.

    • Sonia Boscenco
    • Jacqueline Tait-Mulder
    • Payam A. Gammage
    ResearchOpen Access
    Nature Genetics
    Volume: 57, P: 2705-2714
  • Vaccination efficiency in HIV infection is hampered by the low immunogenicity of HIV-1 Env glycoprotein (Env). Here authors optimise the neutralising antibody response to Env by stabilizing the Env trimers in the context of expressing them in a Newcastle Disease Virus-like particle and providing conditions that mimics replicating virus infection.

    • Kenta Matsuda
    • Mitra Harrison
    • Mark Connors
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-17
  • Pocock et al. reveal that transient activation of 5′ AMP-activated protein kinase and estrogen-related receptor drives robust maturation of multicellular human cardiac organoids, enabling modeling of desmoplakin cardiomyopathy dysfunction, which could be rescued using the bromodomain and extra-terminal inhibitor INCB054329.

    • Mark W. Pocock
    • Janice D. Reid
    • James E. Hudson
    ResearchOpen Access
    Nature Cardiovascular Research
    Volume: 4, P: 821-840
  • Glutamatergic and GABAergic (γ-aminobutyric acid-producing) cortical neuronal activity drives proliferation of small lung cell cancer via paracrine interactions and through synapses formed with tumour cells.

    • Solomiia Savchuk
    • Kaylee M. Gentry
    • Humsa S. Venkatesh
    ResearchOpen Access
    Nature
    Volume: 646, P: 1232-1242